SNCA and Parkinson disease: Furthermore, plasma pS129-α-synuclein concentrations in patients with PD correlated with motor symptom severity measured by the MDS-UPDRS part III scores (r = 0.27 (95% CI: 0.09–0.43), p = 0.004, Spearman correlation analysis, Figure 3B).